No-Cost COVID-19 Testing Ends January 31st

Hidalgo County Public Health Lab to Stop Free COVID 19 Tests Jan. 31st

Community NewsNews
315

Listen to article (english)

Translate to Spanish or other 102 languages!

Beginning February 1, 2026, low-cost laboratory testing services will be available. This includes COVID-19 testing, flu/strep tests, diabetes screenings and much more. Courtesy image. Patient image for illustration purposes
Beginning February 1, 2026, low-cost laboratory testing services will be available. This includes COVID-19 testing, flu/strep tests, diabetes screenings and much more. Courtesy image. Patient image for illustration purposes

Mega Doctor News

- Advertisement -

The Hidalgo County Health & Human Services Department has announced that no-cost COVID-19 testing at the Hidalgo County Public Health Laboratory will conclude on January 31, 2026.

Beginning February 1, 2026, low-cost laboratory testing services will be available. This includes COVID-19 testing, flu/strep tests, diabetes screenings and much more. 

Fees vary by test. Employees and members of the public seeking pricing or appointment information should contact the laboratory directly.

See the image below for more information:

Courtesy image
- Advertisement -
- Advertisement -

Latest news

- Advertisement -
Previous article
MD Anderson Partners with SOPHiA GENETICS to Accelerate Innovation in AI Precision Oncology
Next article
The Importance of Giving the Gift of Life

More Articles

AACT NOW to Launch Rally the Vote Across Rio Grande Valley

The Advocacy Alliance Center of Texas, known as AACT NOW, will officially launch its Rally the Vote initiative Thursday, Oct. 1, bringing together community partners working to expand access to accurate, nonpartisan election information across the Rio Grande Valley.

STHS and Prominence Health Empower Seniors This World Heart Day

World Heart Day serves as a powerful reminder that cardiovascular disease remains one of the greatest threats to the health and well-being of older adults.

DHR Health Offers Mammogram Screening Special During “Breast Cancer Awareness Month”

October is “Breast Cancer Awareness Month,” and DHR Health is encouraging women to prioritize their breast health by offering their annual mammogram screening special.

FDA Approves First Treatment for MCT8 Deficiency

The U.S. Food and Drug Administration approved Emcitate (tiratricol) tablets for oral suspension to treat peripheral thyrotoxicosis (excess thyroid hormone levels in the blood that causes symptoms, such as rapid heart rate, increased blood pressure and adverse effects on metabolism) in patients with MCT8 deficiency, also known as Allan-Herndon-Dudley syndrome.
- Advertisement -